Send to a friend
Photo credit: Chris Norman / Chemonics International
THE LIVE SESSION OF THIS DEBATE HAS ENDED: SCROLL DOWN TO BOTTOM OF PAGE TO READ THE COMMENTS
Concern that microorganisms are becoming resistant to common antimicrobial drugs, such as antibiotics and malaria treatments, is sparking debate across the globe. Antimicrobial resistance could lead to the rise of superbugs, creating a global health security risk — the UN warned last year that the number of deaths caused by antimicrobial resistance could reach 10 million by 2050.
How can policy makers, and antimicrobial producers, prescribers, and users, be encouraged to prevent the overuse of antimicrobials? And what can be done to curb the rise of drug-resistant infections in low- and middle-income countries? Following a panel discussion, run by Chemonics International in partnership with The Economist Intelligence Unit, exploring new and emerging behaviour change strategies aimed at preventing the rise of antimicrobial resistance, we hosted an interactive online debate to further explore these important issues. The two-hour debate included specialist panellists as well as views from SciDev.Net readers, and comments from social media.
- Claire Heffernan, Director, London International Development Centre
- Eric Fèvre, Professor of Veterinary Infectious Diseases at the Institute of Infection and Global Health, University of Liverpool
- Christie Peacock, Founder and Executive Chair, Sidai Africa Ltd
- Wondie Alemu, Antimicrobial Resistance Prevention and Containment Adviser
- Sian Williams, Policy Officer for Wellcome Trust’s Drug-Resistant Infections Priority Programme, supporting Wellcome’s expanding policy and advocacy work on the topic of antimicrobial resistance (AMR).
We asked the panelists, the following questions, along with others raised by our readers:
Scroll down to the comments section below